Aurinia Pharmaceuticals Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Bailey Jeffrey Allen | — | Tax Withholding | 2,716 | $15.68 | $42,587 | 22,775 | Nov 21, 2025 |
| Johnson Craig A | — | Tax Withholding | 6,039 | $15.68 | $94,692 | 14,592 | Nov 21, 2025 |
| TANG KEVIN | — | Purchase | 100,000 | $11.34 | $1,134,000 | 11,129,500 | Aug 1, 2025 |
| Keenan Greg | Chief Medical Officer | Sale | 20,000 | $10.50 | $210,000 | 133,484 | Aug 1, 2025 |
| Keenan Greg | Chief Medical Officer | Sale | 8,305 | $8.23 | $68,350 | 153,484 | Mar 7, 2025 |
| Miller Joseph M | Chief Financial Officer | Award / Grant | 114,711 | — | — | 695,374 | Mar 4, 2025 |
| Robertson Stephen P. | EVP, General Counsel | Award / Grant | 84,106 | — | — | 529,349 | Mar 4, 2025 |
| Greenleaf Peter | Chief Executive Officer | Sale | 164,947 | $7.92 | $1,306,380 | 1,788,945 | Mar 3, 2025 |
| Keenan Greg | Chief Medical Officer | Award / Grant | 62,583 | — | — | 174,028 | Mar 3, 2025 |
| Donley Matthew Maxwell | Chief Operating Officer | Sale | 58,991 | $7.92 | $467,209 | 680,465 | Mar 3, 2025 |
| TANG KEVIN | — | Purchase | 351,962 | $8.02 | $2,822,735 | 9,281,462 | Mar 3, 2025 |
| TANG KEVIN | — | Purchase | 500,000 | $9.09 | $4,545,000 | 8,429,500 | Dec 5, 2024 |
| Smith Karen L. | — | Award / Grant | 12,135 | — | — | 24,807 | Nov 21, 2024 |
| Leversage Jill | — | Award / Grant | 12,135 | — | — | 25,053 | Nov 21, 2024 |
| Johnson Craig A | — | Award / Grant | 20,631 | — | — | 20,631 | Nov 21, 2024 |
| Bailey Jeffrey Allen | — | Award / Grant | 12,135 | — | — | 25,491 | Nov 21, 2024 |
| Jayne David R.W. | — | Award / Grant | 12,135 | — | — | 56,499 | Nov 21, 2024 |
| Bailey Jeffrey Allen | — | Sale | 4,557 | $8.43 | $38,416 | 13,356 | Nov 8, 2024 |
| Smith Karen L. | — | Sale | 5,241 | $8.43 | $44,182 | 12,672 | Nov 8, 2024 |
| Habig Scott Michael | Chief Commercial Officer | Sale | 18,249 | $5.31 | $96,902 | 456,338 | Aug 6, 2024 |
| Balakrishnan Brinda | — | Sale | 520 | $5.74 | $2,985 | 17,523 | May 21, 2024 |
| Billen Daniel | — | Sale | 5,252 | $5.74 | $30,146 | 28,141 | May 21, 2024 |
| Jayne David R.W. | — | Sale | 4,946 | $5.74 | $28,390 | 44,364 | May 21, 2024 |
| Leversage Jill | — | Sale | 5,610 | $5.74 | $32,201 | 12,918 | May 21, 2024 |
| MacKay-Dunn R. Hector | — | Sale | 5,630 | $5.74 | $32,316 | 18,595 | May 21, 2024 |
| Greenleaf Peter | Chief Executive Officer | Sale | 126,981 | $5.60 | $711,094 | 1,522,114 | Mar 6, 2024 |
| Miller Joseph M | Chief Financial Officer | Sale | 34,811 | $5.60 | $194,942 | 495,928 | Mar 6, 2024 |
| Donley Matthew Maxwell | EVP, Ops & Strategy | Sale | 40,665 | $5.51 | $224,064 | 584,072 | Mar 6, 2024 |
| Habig Scott Michael | Chief Commercial Officer | Sale | 17,777 | $5.60 | $99,551 | 474,587 | Mar 6, 2024 |
| Robertson Stephen P. | EVP, General Counsel | Sale | 57,745 | $5.60 | $323,372 | 443,824 | Mar 6, 2024 |
| Knappertz Volker | EVP, Research and Development | Sale | 4,930 | $6.10 | $30,073 | 319,128 | Feb 27, 2024 |
| Knappertz Volker | EVP, Research and Development | Sale | 25,146 | $5.48 | $137,800 | 324,058 | Feb 20, 2024 |
| Habig Scott Michael | Chief Commercial Officer | Award / Grant | 195,512 | — | — | 508,231 | Feb 20, 2024 |
| Donley Matthew Maxwell | EVP, Ops & Strategy | Award / Grant | 216,666 | — | — | 624,737 | Feb 20, 2024 |
| Robertson Stephen P. | EVP, General Counsel | Award / Grant | 194,230 | — | — | 501,569 | Feb 20, 2024 |
| Miller Joseph M | Chief Financial Officer | Award / Grant | 196,153 | — | — | 530,739 | Feb 20, 2024 |
| Greenleaf Peter | Chief Executive Officer | Award / Grant | 661,538 | — | — | 1,649,095 | Feb 20, 2024 |
| Billen Daniel | — | Award / Grant | 9,310 | — | — | 38,043 | May 23, 2023 |
| Balakrishnan Brinda | — | Option Exercise | 8,733 | — | — | 8,733 | May 19, 2023 |
| MacKay-Dunn R. Hector | — | Option Exercise | 8,733 | — | — | 19,733 | May 19, 2023 |
| Leversage Jill | — | Option Exercise | 8,733 | — | — | 14,033 | May 19, 2023 |
| Jayne David R.W. | — | Award / Grant | 9,310 | — | — | 58,043 | May 18, 2023 |
| Hagan Joseph P | — | Sale | 272 | $10.58 | $2,878 | 11,961 | May 18, 2023 |
| MILNE GEORGE M JR | — | Option Exercise | 8,733 | — | — | 78,733 | May 18, 2023 |
| Robertson Stephen P. | EVP, General Counsel | Sale | 19,644 | $8.78 | $172,474 | 303,122 | Mar 2, 2023 |
| Miller Joseph M | Chief Financial Officer | Sale | 11,398 | $8.78 | $100,074 | 331,112 | Mar 2, 2023 |
| Greenleaf Peter | Chief Executive Officer | Sale | 33,047 | $8.78 | $290,153 | 982,671 | Mar 2, 2023 |
| MILNE GEORGE M JR | — | Purchase | 20,000 | $8.91 | $178,200 | 70,000 | Mar 2, 2023 |
| Donley Matthew Maxwell | EVP, Ops & Strategy | Award / Grant | 271,134 | — | — | 403,141 | Mar 2, 2023 |
| Miller Joseph M | Chief Financial Officer | Sale | 11,296 | $8.94 | $100,986 | 331,214 | Mar 2, 2023 |